Compare Stocks: DRTS, TFX, HAE, and ITGR

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DRTS Alpha Tau Medical	$14.48 -2.8%	$14.22	$3.43 ▼ $15.79	$1.31B	1.22	586,455 shs	427,279 shs
HAE Haemonetics	$103.72 -0.9%	$99.89	$48.17 ▼ $110.45	$4.72B	0.61	811,557 shs	542,039 shs
ITGR Integer	$126.49 +0.0%	$124.11	$62.00 ▼ $126.79	$4.30B	0.58	773,327 shs	312,027 shs
TFX Teleflex	$124.96 -0.2%	$133.12	$100.18 ▼ $145.00	$5.31B	0.83	782,011 shs	683,315 shs

The Best Nuclear Energy Stocks to Buy

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DRTS Alpha Tau Medical	+0.81%	-1.00%	-0.93%	+16.69%	+245.48%
HAE Haemonetics	+0.08%	-0.73%	+1.80%	+39.73%	+108.08%
ITGR Integer	+0.12%	+0.21%	+0.17%	+37.91%	+20.35%
TFX Teleflex	+0.92%	-1.96%	-9.27%	-6.02%	-4.30%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DRTS Alpha Tau Medical	$14.48 -2.8%	$14.22	$3.43 ▼ $15.79	$1.31B	1.22	586,455 shs	427,279 shs
HAE Haemonetics	$103.72 -0.9%	$99.89	$48.17 ▼ $110.45	$4.72B	0.61	811,557 shs	542,039 shs
ITGR Integer	$126.49 +0.0%	$124.11	$62.00 ▼ $126.79	$4.30B	0.58	773,327 shs	312,027 shs
TFX Teleflex	$124.96 -0.2%	$133.12	$100.18 ▼ $145.00	$5.31B	0.83	782,011 shs	683,315 shs

The Best Nuclear Energy Stocks to Buy

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DRTS Alpha Tau Medical	+0.81%	-1.00%	-0.93%	+16.69%	+245.48%
HAE Haemonetics	+0.08%	-0.73%	+1.80%	+39.73%	+108.08%
ITGR Integer	+0.12%	+0.21%	+0.17%	+37.91%	+20.35%
TFX Teleflex	+0.92%	-1.96%	-9.27%	-6.02%	-4.30%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DRTS Alpha Tau Medical	2.38	Hold	$15.40	6.35% Upside
HAE Haemonetics	2.73	Moderate Buy	$99.78	-3.80% Downside
ITGR Integer	2.07	Hold	$109.86	-13.15% Downside
TFX Teleflex	2.67	Moderate Buy	$155.20	24.20% Upside

Current Analyst Ratings Breakdown

Latest DRTS, TFX, HAE, and ITGR Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/28/2026	TFX Teleflex	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$145.00 ➝ $158.00
9/24/2026	TFX Teleflex	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
9/21/2026	TFX Teleflex	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D)
9/14/2026	ITGR Integer	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold (C)
9/3/2026	HAE Haemonetics	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$105.00 ➝ $125.00
9/3/2026	DRTS Alpha Tau Medical	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$17.00 ➝ $30.00
9/1/2026	DRTS Alpha Tau Medical	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold ➝ Strong Sell
8/25/2026	TFX Teleflex	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$159.00 ➝ $170.00
8/21/2026	HAE Haemonetics	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$96.00 ➝ $119.00
8/19/2026	HAE Haemonetics	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$95.00 ➝ $118.00
8/18/2026	HAE Haemonetics	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$96.00 ➝ $110.00

(Data available from 10/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DRTS Alpha Tau Medical	N/A	N/A	N/A	N/A	$0.88 per share	N/A
HAE Haemonetics	$1.33B	3.54	$7.51 per share	13.81	$17.14 per share	6.05
ITGR Integer	$1.85B	2.32	$10.37 per share	12.20	$49.85 per share	2.54
TFX Teleflex	$2.25B	2.35	$11.27 per share	11.09	$70.71 per share	1.77

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DRTS Alpha Tau Medical	-$42.63M	-$1.04	N/A	N/A	N/A	N/A	-138.12%	-81.68%	11/19/2026 (Estimated)
HAE Haemonetics	$97.31M	$2.04	50.85	18.10	2.10	7.12%	27.55%	9.65%	11/5/2026 (Estimated)
ITGR Integer	$102.81M	$3.66	34.56	18.85	2.40	6.97%	12.79%	6.48%	10/22/2026 (Estimated)
TFX Teleflex	-$905.64M	-$23.29	N/A	11.48	0.83	-39.67%	11.93%	5.44%	11/5/2026 (Estimated)

Latest DRTS, TFX, HAE, and ITGR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
10/22/2026	Q3 2026	ITGR Integer	$1.68	N/A	N/A	N/A	$456.91 million	N/A
8/10/2026	Q2 2026	DRTS Alpha Tau Medical	-$0.1409	-$0.50	-$0.3591	-$0.50	$0.14 million	N/A
8/6/2026	Q1 2027	HAE Haemonetics	$1.08	$1.14	+$0.06	$0.72	$327.86 million	$339.38 million
8/6/2026	Q2 2026	TFX Teleflex	$1.28	$1.76	+$0.48	$2.28	$559.59 million	$570.33 million
8/3/2026	Q2 2026	ITGR Integer	$1.38	$1.60	+$0.22	$0.69	$451.07 million	$464.11 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
DRTS Alpha Tau Medical	N/A	N/A	N/A	N/A	N/A
HAE Haemonetics	N/A	N/A	N/A	N/A	N/A
ITGR Integer	N/A	N/A	N/A	N/A	N/A
TFX Teleflex	$1.36	1.09%	N/A	N/A	N/A

Latest DRTS, TFX, HAE, and ITGR Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/4/2026	TFX Teleflex	quarterly	$0.34	0.99%	8/14/2026	8/14/2026	9/30/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DRTS Alpha Tau Medical	0.15	11.09	7.79
HAE Haemonetics	1.40	3.08	1.91
ITGR Integer	0.75	3.73	2.41
TFX Teleflex	0.94	2.60	2.12

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
DRTS Alpha Tau Medical	2.65%
HAE Haemonetics	99.67%
ITGR Integer	99.29%
TFX Teleflex	95.62%

Insider Ownership

Company	Insider Ownership
DRTS Alpha Tau Medical	39.50%
HAE Haemonetics	2.07%
ITGR Integer	1.10%
TFX Teleflex	0.70%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
DRTS Alpha Tau Medical	121	90.33 million	54.65 million	No Data
HAE Haemonetics	3,009	45.50 million	44.56 million	Optionable
ITGR Integer	11,000	34.00 million	33.62 million	Optionable
TFX Teleflex	15,500	42.37 million	42.08 million	Optionable

DRTS, TFX, HAE, and ITGR Headlines

Recent News About These Companies

TFX or SONVY: Which Is the Better Value Stock Right Now?

October 6 at 12:41 PM | zacks.com

Is It Prudent to Add Teleflex Stock to Your Portfolio Now?

October 6 at 12:31 PM | zacks.com

Teleflex Incorporated (NYSE:TFX) Receives Consensus Rating of "Moderate Buy" from Analysts

October 6 at 2:28 AM | americanbankingnews.com

Teleflex Incorporated (NYSE:TFX) Stock Now Rated "Moderate Buy" by Wall Street Brokerages

October 6 at 2:28 AM | marketbeat.com

RBC Capital Reaffirms Their Buy Rating on Teleflex (TFX)

October 4 at 9:12 AM | theglobeandmail.com

Teleflex study links catheter technology to 70% lower CLABSI risk

September 29, 2026 | streetinsider.com

Teleflex Announces Latest Peer-Reviewed Study Demonstrates a Significant Reduction in CLABSI Risk with Arrowg+ard™ Technology

September 29, 2026 | businesswire.com

Teleflex (TFX) Soars 4.4%: Is Further Upside Left in the Stock?

September 29, 2026 | zacks.com

Should New Leadership And Debt Focus At Teleflex (TFX) Require Action From Investors?

September 28, 2026 | finance.yahoo.com

Update: BofA Upgrades Teleflex to Buy From Neutral, Adjusts Price Target to $158 From $145

September 28, 2026 | finance.yahoo.com

Why Teleflex (TFX) Stock Is Trading Up Today

September 28, 2026 | markets.financialcontent.com

Why Teleflex (TFX) Stock Is Up Today

September 28, 2026 | quiverquant.comQ

Teleflex Growth Prospects, New Leadership Could Drive 2027 Re-Rating, BofA Securities Says

September 28, 2026 | finance.yahoo.com

B of A Securities Upgrades Teleflex to Buy from Neutral

September 28, 2026 | msn.com

Teleflex (NYSE:TFX) Shares Up 3.8% Following Analyst Upgrade

September 28, 2026 | marketbeat.com

BofA Upgrades Teleflex to Buy From Neutral, Price Target is $158

September 28, 2026 | marketscreener.comM

BofA Upgrades Teleflex to Buy From Neutral, Adjusts Price Target to $158 From $145

September 28, 2026 | marketscreener.comM

Teleflex (NYSE:TFX) Stock Rating Upgraded by Bank of America

September 28, 2026 | americanbankingnews.com

Bank of America Upgrades Teleflex (NYSE:TFX) to "Buy"

September 28, 2026 | marketbeat.com

Zacks Research Upgrades Teleflex (NYSE:TFX) to "Strong-Buy"

September 26, 2026 | marketbeat.com

Teleflex stock heads into the open after a 0.94 percent drop

September 23, 2026 | ad-hoc-news.deA

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

DRTS, TFX, HAE, and ITGR Company Descriptions

Alpha Tau Medical NASDAQ:DRTS

$14.48 -0.41 (-2.75%)

Closing price 04:00 PM Eastern

Extended Trading

$14.74 +0.25 (+1.76%)

As of 06:43 PM Eastern

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.

Haemonetics NYSE:HAE

$103.72 -0.96 (-0.91%)

Closing price 03:59 PM Eastern

Extended Trading

$103.58 -0.14 (-0.14%)

As of 06:11 PM Eastern

Haemonetics Corporation, a healthcare company, provides suite of medical products and solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 app. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE products comprising VASCADE and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen. The company sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.

Integer NYSE:ITGR

$126.48 +0.04 (+0.03%)

Closing price 03:59 PM Eastern

Extended Trading

$126.48 0.00 (0.00%)

As of 05:19 PM Eastern

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

Teleflex NYSE:TFX

$124.96 -0.28 (-0.22%)

Closing price 03:59 PM Eastern

Extended Trading

$124.64 -0.32 (-0.26%)

As of 06:02 PM Eastern

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest DRTS, TFX, HAE, and ITGR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest DRTS, TFX, HAE, and ITGR Earnings

Compare Dividends

Latest DRTS, TFX, HAE, and ITGR Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

DRTS, TFX, HAE, and ITGR Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

DRTS, TFX, HAE, and ITGR Company Descriptions

Alpha Tau Medical NASDAQ:DRTS

Haemonetics NYSE:HAE

Integer NYSE:ITGR

Teleflex NYSE:TFX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools